Literature DB >> 15918785

Necrotizing fasciitis: pathogenesis and treatment.

Michael H Young1, David M Aronoff, N Cary Engleberg.   

Abstract

Necrotizing fasciitis is a rapidly progressive, life-threatening infection and a true infectious disease emergency. Despite much clinical experience, the management of this disease remains suboptimal, with mortality rates remaining approximately 30%. Necrotizing fasciitis rarely presents with obvious signs and symptoms and delays in diagnosis enhance mortality. Therefore, successful patient care depends on the physician's acumen and index of suspicion. Prompt surgical debridement, intravenous antibiotics, fluid and electrolyte management, and analgesia are mainstays of therapy. Adjunctive clindamycin, hyperbaric oxygen therapy and intravenous immunoglobulin are frequently employed in the treatment of necrotizing fasciitis, but their efficacy has not been rigorously established. Improved understanding of the pathogenesis of necrotizing fasciitis has revealed new targets for rationally designed therapies to improve morbidity and mortality.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15918785     DOI: 10.1586/14787210.3.2.279

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN: 1478-7210            Impact factor:   5.091


  30 in total

1.  Adjunctive hyperbaric oxygen treatment for necrotising soft-tissue infections: A systematic review and meta-analysis.

Authors:  Morten Hedetoft; Michael H Bennett; Ole Hyldegaard
Journal:  Diving Hyperb Med       Date:  2021-03-31       Impact factor: 0.887

Review 2.  The Unexpected Impact of Vaccines on Secondary Bacterial Infections Following Influenza.

Authors:  Amber M Smith; Victor C Huber
Journal:  Viral Immunol       Date:  2017-11-17       Impact factor: 2.257

3.  The fibrinogen-binding M1 protein reduces pharyngeal cell adherence and colonization phenotypes of M1T1 group A Streptococcus.

Authors:  Ericka L Anderson; Jason N Cole; Joshua Olson; Bryan Ryba; Partho Ghosh; Victor Nizet
Journal:  J Biol Chem       Date:  2013-12-19       Impact factor: 5.157

Review 4.  Molecular insight into invasive group A streptococcal disease.

Authors:  Jason N Cole; Timothy C Barnett; Victor Nizet; Mark J Walker
Journal:  Nat Rev Microbiol       Date:  2011-09-16       Impact factor: 60.633

5.  Multidisciplinary management of periocular necrotising fasciitis: a series of 11 patients.

Authors:  K Tambe; A Tripathi; J Burns; R Sampath
Journal:  Eye (Lond)       Date:  2011-12-09       Impact factor: 3.775

6.  Necrotizing fasciitis: a surgical emergency.

Authors:  Damiano de Tullio; Camilla Rossi; Stefano Bolzon; Lucia Scagliarini; Savino Occhionorelli
Journal:  Updates Surg       Date:  2010-09-09

7.  Predictors of Monomicrobial Necrotizing Soft Tissue Infections.

Authors:  Rhett N Willis; Christopher A Guidry; Christopher B Horn; Daniel Gilsdorf; Stephen W Davies; Zachary C Dietch; Robert G Sawyer
Journal:  Surg Infect (Larchmt)       Date:  2015-06-25       Impact factor: 2.150

8.  Decreased necrotizing fasciitis capacity caused by a single nucleotide mutation that alters a multiple gene virulence axis.

Authors:  Randall J Olsen; Izabela Sitkiewicz; Ara A Ayeras; Vedia E Gonulal; Concepcion Cantu; Stephen B Beres; Nicole M Green; Benfang Lei; Tammy Humbird; Jamieson Greaver; Ellen Chang; Willie P Ragasa; Charles A Montgomery; Joiner Cartwright; Allison McGeer; Donald E Low; Adeline R Whitney; Philip T Cagle; Terry L Blasdel; Frank R DeLeo; James M Musser
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-04       Impact factor: 11.205

9.  Cervical necrotizing fasciitis: descriptive, retrospective analysis of 59 cases treated at a single center.

Authors:  Johanna Elander; Michael Nekludov; Agneta Larsson; Britt Nordlander; Staffan Eksborg; Jonas Hydman
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-06-10       Impact factor: 2.503

10.  The secreted esterase of group a streptococcus is important for invasive skin infection and dissemination in mice.

Authors:  Hui Zhu; Mengyao Liu; Paul Sumby; Benfang Lei
Journal:  Infect Immun       Date:  2009-10-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.